Cynthia K Lee is a prominent inventor based in Needham, MA, known for her significant contributions to the field of vaccine development. With a total of six patents to her name, she has made remarkable strides in enhancing the stability and efficacy of vaccines.

Latest Patents

One of her latest patents is a vaccine stabilizer formulation that enhances the thermostability and shelf-life of biological products. This formulation includes a tertiary amine N-oxide or a derivative, an inorganic salt, glutamic acid or a salt thereof, a polyol, a physiologically acceptable buffer, and a pharmaceutically acceptable carrier. The tertiary amine N-oxide may be trimethylamine-N-oxide, which is useful for vaccine stabilization. Another notable patent involves a high yield yellow fever virus strain that has been adapted to propagate in cells, resulting in an inactive, non-replicating vaccine. This vaccine comprises a whole virion, chemically inactivated Yellow Fever virus, which preserves critical, neutralizing epitopes and provides methods for preventing Yellow Fever viral infection.

Career Highlights

Cynthia has worked with notable companies such as GE Healthcare Bio-Sciences Corporation and Acambis Inc. Her work has significantly impacted the field of vaccine research and development.

Collaborations

Throughout her career, Cynthia has collaborated with esteemed colleagues, including Thomas P Monath and Harold Kleanthous, further enhancing her contributions to the field.

Conclusion

Cynthia K Lee's innovative work in vaccine stabilization and development showcases her dedication to improving public health through scientific advancements. Her patents reflect her expertise and commitment to creating effective solutions in the medical field.

This text is generated by artificial intelligence and may not be accurate.